Colonoscopy evaluation after short-term anti-tuberculosis treatment in nonspecific ulcers on the ileocecal area

Table 2 Colonoscopy features before anti-tuberculosis medication trial

Group	Tbc colitis (n = 7 )	Nonspecific ulcers ( n = 18)		P1
		Suspicious tbc colitis (n = 9 )	Suspicious IBD (n = 9 )
Location of lesion (%)
Terminal ileum	3 (42.9)	5 (55.6)	6 (66.7)	NS
IC valve	5 (71.4)	8 (88.9)	7 (77.8)	NS
Cecum	2 (28.6)	2 (22.2)	5 (55.6)	NS
Prox. Ascending colon	6 (85.7)	6 (66.7)	6 (66.7)	NS
Shape of lesion
Geographic ulcer	3 (42.9)	2 (22.2)	2 (22.2)	NS
Irregular ulcer	1 (14.3)	3 (33.3)	5 (55.6)	NS
Aphthous ulcer	0 (0)	2 (22.2)	6 (66.7)	0.01
Transverse ulcer	3 (42.6)	2 (22.2)	2 (22.2)	NS
Stenosis	2 (28.6)	1 (11.1)	2 (22.2)	NS
Pathology (%)
Granuloma	2 (28.6)	3 (28.0)	4 (44.4)	NS
Caseating granuloma	4 (57.1)	0 (0)	0 (0)	0.01
Acid fast bacilli+	3 (21.7)	0 (0)	0 (0)	0.01
Non-specific inflammation	0 (0)	6 (66.7)	5 (55.6)	0.02

NS: Not significant.

¹Significant at P < 0.05 by Fisher’s exact test.